论文部分内容阅读
加拿大安大略伦敦消息:西安大略大学(UWO)的研究人员对批准进行环孢菌素治疗胰岛素依赖型糖尿病的多中心研究表示欢迎,主要研究人员Colvin Stiller(UWO内科教授和大学医院多脏器移植部主任)在3月末开始进行有对照的临床试验。 Stiler:去年报告了免疫抑制疗法的试验性研究结果(《Med Post》1984;2月21日),在诊断6周内开始环孢菌素治疗的一组30名病人中,有一半以上用药后得到完全缓解。据健康保护分布(HPB)药品局长IanHenderson说,此项研究的报道在加拿大医生
LONDON, ONTARIO, CANADA Researchers at the University of Western Ontario (UWO) welcomed the multicentre study approving cyclosporin for insulin-dependent diabetes, led by Colvin Stiller, a professor of internal medicine at UWO and the Department of Multiple Organ Transplantation at the University Hospital Director) started a controlled clinical trial in late March. Stiler: Last year we reported the results of a pilot study of immunosuppressive therapy (“Med Post” 1984; February 21). More than half of a group of 30 patients who started cyclosporin therapy within 6 weeks Get completely relieved. According to IanHenderson, director of the Health Protection Distribution (HPB) drug agency, the study was reported in a Canadian doctor